DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
Jonathan F Goodwin1, Vishal Kothari2, Justin M Drake3
1Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Abstract:
Emerging evidence demonstrates that the DNA repair kinase DNA-PKcs exerts divergent roles in transcriptional regulation of unsolved consequence. Here, in vitro and in vivo interrogation demonstrate that DNA-PKcs functions as a selective modulator of transcriptional networks that induce cell migration, invasion, and metastasis. Accordingly, suppression of DNA-PKcs inhibits tumor metastases. Clinical assessment revealed that DNA-PKcs is significantly elevated in advanced disease and independently predicts for metastases, recurrence, and reduced overall survival. Further investigation demonstrated that DNA-PKcs in advanced tumors is highly activated, independent of DNA damage indicators. Combined, these findings reveal unexpected DNA-PKcs functions, identify DNA-PKcs as a potent driver of tumor progression and metastases, and nominate DNA-PKcs as a therapeutic target for advanced malignancies.
Insights
The DNA repair kinase DNA-PKcs drives tumor cell migration, invasion, and metastasis. Inhibiting DNA-PKcs can suppress cancer spread and improve survival, identifying it as a therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The DNA repair kinase DNA-PKcs has known roles in DNA repair.
- Its functions in transcriptional regulation are not fully understood.
- Emerging evidence suggests broader roles in cellular processes.
Purpose of the Study:
- To investigate the role of DNA-PKcs in transcriptional regulation.
- To determine if DNA-PKcs modulates processes like cell migration, invasion, and metastasis.
- To evaluate DNA-PKcs as a potential therapeutic target in advanced cancers.
Main Methods:
- In vitro and in vivo experimental models were used.
- DNA-PKcs activity was modulated (suppressed).
- Tumor metastasis, cell migration, and invasion were assessed.
- Clinical samples were analyzed for DNA-PKcs levels and activation status.
Main Results:
- DNA-PKcs selectively modulates transcriptional networks driving cell migration, invasion, and metastasis.
- Suppression of DNA-PKcs significantly inhibited tumor metastases.
- Elevated DNA-PKcs levels in advanced cancers independently predicted for metastases, recurrence, and reduced survival.
- DNA-PKcs in advanced tumors showed high activation, irrespective of DNA damage indicators.
Conclusions:
- DNA-PKcs possesses previously unrecognized functions in promoting tumor progression.
- DNA-PKcs is a significant driver of metastasis and a negative prognostic factor in advanced malignancies.
- DNA-PKcs represents a promising therapeutic target for treating advanced cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation


